Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The increasing number of infections and disease worldwide had led to increasing research and development in pharmaceutical, clinical and healthcare sector. The antimicrobial susceptibility testing has a played key role in the research and development laboratory to perform on bacterial isolates. The different method are been performed for the identification and precise results. Besides growing research project and laboratory had led to the demand for antimicrobial susceptibility testing market. The market is expected to witness growth at significant rate during the forecast period.
The market is driven by emergence of multidrug-resistance due to drug abuse. Besides growing government initiatives to detect and control antimicrobial-resistant species is fueling the growth of antimicrobial susceptibility testing market. Also, increasing funding, research grants, and public-private investments in the market for research of different infection and their susceptibility is propelling the growth of market. Moreover, rising incidence of infectious diseases coupled with epidemic & pandemic events had led to demand from the major end user consumers. Besides Technological advancements in microbiology, infectious disease, healthcare, clinical research is ultimately fueling the demand for antimicrobial susceptibility testing market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the antimicrobial susceptibility testing market. In addition, complete analysis of changes on the antimicrobial susceptibility testing market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 had a positive impact on antimicrobial susceptibility testing market owing to widely used for detection and further fore research and development.
The antimicrobial susceptibility testing market is segmented based on product, type, method, application, end user and geography.
The antimicrobial susceptibility testing is available in market according to various products including manual antimicrobial susceptibility testing products, automated laboratory instruments, culture and growth media, consumables. Manual antimicrobial susceptibility testing products is projected to lead in the market owing to different products available under manual antimicrobial susceptibility testing including antimicrobial susceptibility disks, susceptibility plates for manual reading, susceptibility hardware and media. The demand for these products is driving the growth of antimicrobial susceptibility testing products.
The antimicrobial susceptibility testing is present in different type like antibacterial susceptibility testing, antifungal susceptibility testing, and antiparasitic susceptibility testing. Antimicrobial susceptibility tests is expected to lead and gain major market share in global antimicrobial susceptibility testing market. The growth is due to its major use in screening of drugs .Beside it help clinical research and physicians for drug choice and dosage for chronic infection treatment
The antimicrobial susceptibility testing is performed by different method like agar dilution, automated susceptibility testing instruments, disk diffusion, etest method and genotyping methods. Automated susceptibility testing instruments is expected to dominate in the antimicrobial susceptibility testing market owing to rapid and fast identification of pathogen present.
The antimicrobial susceptibility testing market find its application in clinical diagnostics, drug discovery and development, epidemiology. The clinical diagnostics is anticipated to lead in the market due to use of antimicrobial susceptibility testing for detecting common pathogens and are major used to check the susceptibility to drugs for specific infections. Besides, clinical diagnostics has major role for providing results for different infection disease research where major antimicrobial susceptibility testing is been used for detection which is ultimately fueling the demand for market.
The antimicrobial susceptibility testing market has end user in clinical research organizations (cros), hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research &academic institutes. Pharmaceutical and biotechnology companies is projected to lead in the segment for antimicrobial susceptibility testing market owing to use of product for detection and determine the antimicrobial growth which can further inhibit the growth of these bacteria or fungi. Besides antimicrobial susceptibility testing helps pharmaceutical and biotechnology companies to regulate the drug which are more likely to be effective for particular infection.
Geographically antimicrobial susceptibility testing market is studied for the following region North America, Europe, Asia Pacific and RoW. North America is anticipated to lead in the antimicrobial susceptibility testing market. The growth is due to emerging technological advancement in the region. Beside the developing region has major focused in research and development of products which is driving the growth of the market in the region. Besides presence of key players in the region and demand from end use consumer base is fueling the growth of antimicrobial susceptibility testing market. Besides Europe is expected to have significant growth during the forecast period. However, Asia Pacific is projected to witness growth at highest rate during the forecast period.
The key players in antimicrobial susceptibility testing market are Biomérieux Sa, Accelerate Diagnostics, Inc., Alifax S.R.L., Becton, Dickinson And Company, Bioanalyse, Bio-Rad Laboratories, Inc., Bruker, Condalab, Creative Diagnostics, Danaher Corporation, Elitech group, Genefluidics, Inc., Himedia Laboratories, Liofilchem S.R.L., Mast Group Ltd., Merck Kgaa, Roche Diagnostics, Synbiosis, Thermo Fisher Scientific and Zhuhai Dl Biotech Co., Ltd. among others.
The report analyses the global antimicrobial susceptibility testing market based on product, type, method, application, end user and geography. The antimicrobial susceptibility testing is available in market according to various products including manual antimicrobial susceptibility testing products, automated laboratory instruments, culture and growth media, consumables. The antimicrobial susceptibility testing is present in different type like antibacterial susceptibility testing, antifungal susceptibility testing, and antiparasitic susceptibility testing. The antimicrobial susceptibility testing is performed by different method like agar dilution, automated susceptibility testing instruments, disk diffusion, etest method and genotyping methods. The market find its application in clinical diagnostics, drug discovery and development, epidemiology. The market has end user in clinical research organizations (cros), hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research &academic institutes. Geographically antimicrobial susceptibility testing market is studied for the following region North America, Europe, Asia Pacific and RoW.
The key players in antimicrobial susceptibility testing market are Biomérieux Sa, Accelerate Diagnostics, Inc., Alifax S.R.L., Becton, Dickinson And Company, Bioanalyse, Bio-Rad Laboratories, Inc., Bruker, Condalab, Creative Diagnostics, Danaher Corporation, Elitech group, Genefluidics, Inc., Himedia Laboratories, Liofilchem S.R.L., Mast Group Ltd., Merck Kgaa, Roche Diagnostics, Synbiosis, Thermo Fisher Scientific and Zhuhai Dl Biotech Co., Ltd. among others.
Why to buy this report:
